The leukemogenic transcription factor E2a-Pbx1 induces expression of the putative N-myc and p53 target gene NDRG1 in Ba/F3 cells

Leukemia

Volumn 15, Issue 3, 2001, Pages 362-370

  Rutherford, M N ^a   Bayly, G R L ^a   Matthews, B P ^a   Okuda, T ^b   Dinjens, W M N ^c   Kondoh, H ^b   LeBrun, D P ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b OSAKA UNIVERSITY   (Japan)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

E2a Pbx1; Leukemia; Ndr1; NDRG1; Representational difference analysis; RTP

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; GENE PRODUCT; HYBRID PROTEIN; ONCOPROTEIN; PROTEIN NDRG1; PROTEIN P53; RECOMBINANT INTERLEUKIN 3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2A PBX1; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANALYSIS; APOPTOSIS; ARTICLE; BONE MARROW; CELL CYCLE; CELL LINE; CHILD; CHIMERA; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; CYTOSTASIS; GENE ACTIVATION; GENE TARGETING; HUMAN; HUMAN CELL; LEUKEMOGENESIS; ONCOGENE; ONCOGENE C MYB; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPRESENTATIONAL DIFFERENCE ANALYSIS; TRANSCRIPTION INITIATION;

EID: 0035086097     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402059     Document Type: Article

References (42)

1. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor
2. Structure and function of helix-loop-helix proteins
3. A new transcriptional-activation motif restricted to a class of helix-loop-helix proteins is functionally conserved in both yeast and mammalian cells
4. The E2A gene product contains two separable and functionally distinct transcription activation domains
5. The helix-loop-helix gene E2A is required for B cell formation
6. E2a proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements
7. E2A deficiency leads to abnormalities in α/β T-cell development and to rapid development of T-cell lymphomas
8. Homeodomain proteins
9. Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes
10. Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins
11. Cooperative interactions between HOX and PBX proteins mediated by a conserved peptide motif
12. The Hox-cofactor Pbx1 is required for normal development of proximal limb and axial skeleton and for spleen morphogenesis
13. Transformation properties of the E2a-Pbx1 chimeric oncoprotein: Fusion with E2a is essential, but the Pbx1 homeodomain is dispensable
14. E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice
15. Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice
16. E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts
17. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1
18. mAngiogenin-3, a target gene of oncoprotein E2a-Pbx1, encodes a new angiogenic member of the angiogenin family
19. A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1
20. The gene encoding the granulocyte colony-stimulating factor receptor is a target for deregulation in pre-B ALL by the t(1;19)-specific oncoprotein E2A-Pbx1
21. Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia
22. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1
23. Identifying differences in mRNA expression by representational difference analysis of cDNA
24. Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78/BiP and novel genes
25. A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms
26. Cap43, a novel gene specifically induced by Ni2+ compounds
27. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage
28. Identification and classification of p53-regulated genes
29. N-myc-dependent repression of Ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant
30. Cloning and characterization of TDD5, an androgen target gene that is differentially repressed by testosterone and dihydrotestosterone
31. Chimeric oncoprotein E2a-Pbx1 induces apoptosis of hematopoietic cells by a p53-independent mechanism that is suppressed by Bcl-2
32. Human papillomavirus E6 and E7: Proteins which deregulate the cell cycle
33. Growth factor modulation of p53-mediated growth arrest versus apoptosis
34. P53, the cellular gatekeeper for growth and division
35. Viral oncoproteins discriminate between p53 and the p53 homolog p73
36. The differentiation-related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells
37. Expression of differentiation-related genes in colorectal cancer: Possible implications for prognosis
38. Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells
39. Identification of a stress-induced protein during human trophoblast differentiation by differential display analysis
40. Apoptosis in human chorionic villi and decidua during normal embryonic development and spontaneous abortion in the first trimester
41. Apoptosis and Fas expression in human fetal membranes
42. A tale of three fingers: The family of mammalian Sp/XKLF transcription factors